Annual Net Income:
-$130.87M-$60.08M(-84.86%)Summary
- As of today, EYPT annual net profit is -$130.87 million, with the most recent change of -$60.08 million (-84.86%) on December 31, 2024.
- During the last 3 years, EYPT annual net income has fallen by -$72.45 million (-124.03%).
- EYPT annual net income is now -1595.14% below its all-time high of $8.75 million, reached on June 30, 2010.
Performance
EYPT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Net Income:
-$59.43M-$14.23M(-31.49%)Summary
- As of today, EYPT quarterly net profit is -$59.43 million, with the most recent change of -$14.23 million (-31.49%) on June 30, 2025.
- Over the past year, EYPT quarterly net income has dropped by -$28.60 million (-92.78%).
- EYPT quarterly net income is now -258.21% below its all-time high of $37.56 million, reached on September 30, 2006.
Performance
EYPT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Net Income:
-$175.38M-$28.60M(-19.48%)Summary
- As of today, EYPT TTM net profit is -$175.38 million, with the most recent change of -$28.60 million (-19.48%) on June 30, 2025.
- Over the past year, EYPT TTM net income has dropped by -$88.56 million (-102.00%).
- EYPT TTM net income is now -892.49% below its all-time high of $22.13 million, reached on September 30, 2006.
Performance
EYPT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
EYPT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -84.9% | -92.8% | -102.0% |
| 3Y3 Years | -124.0% | -206.2% | -129.2% |
| 5Y5 Years | -130.4% | -358.9% | -334.8% |
EYPT Net Income Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -124.0% | at low | -371.2% | at low | -147.7% | at low |
| 5Y | 5-Year | -188.3% | at low | -1463.4% | at low | -334.8% | at low |
| All-Time | All-Time | -1595.1% | at low | -258.2% | +6.5% | -892.5% | at low |
EYPT Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$59.43M(-31.5%) | -$175.38M(-19.5%) |
| Mar 2025 | - | -$45.20M(-9.2%) | -$146.78M(-12.2%) |
| Dec 2024 | -$130.87M(-84.9%) | -$41.40M(-41.0%) | -$130.87M(-26.4%) |
| Sep 2024 | - | -$29.36M(+4.8%) | -$103.57M(-19.3%) |
| Jun 2024 | - | -$30.83M(-5.3%) | -$86.82M(-10.0%) |
| Mar 2024 | - | -$29.28M(-107.7%) | -$78.92M(-11.5%) |
| Dec 2023 | -$70.80M(+30.8%) | -$14.10M(-11.8%) | -$70.80M(+29.3%) |
| Sep 2023 | - | -$12.61M(+45.0%) | -$100.15M(+5.5%) |
| Jun 2023 | - | -$22.92M(-8.3%) | -$105.96M(-3.4%) |
| Mar 2023 | - | -$21.16M(+51.3%) | -$102.44M(-0.2%) |
| Dec 2022 | -$102.25M(-75.0%) | -$43.45M(-135.9%) | -$102.25M(-30.7%) |
| Sep 2022 | - | -$18.42M(+5.1%) | -$78.23M(-2.3%) |
| Jun 2022 | - | -$19.41M(+7.5%) | -$76.51M(-14.0%) |
| Mar 2022 | - | -$20.98M(-7.9%) | -$67.11M(-14.9%) |
| Dec 2021 | -$58.42M(-28.7%) | -$19.43M(-16.4%) | -$58.42M(-7.3%) |
| Sep 2021 | - | -$16.70M(-66.8%) | -$54.45M(-31.0%) |
| Jun 2021 | - | -$10.01M(+18.5%) | -$41.56M(+6.6%) |
| Mar 2021 | - | -$12.28M(+20.6%) | -$44.50M(+2.0%) |
| Dec 2020 | -$45.39M(+20.1%) | -$15.47M(-307.0%) | -$45.39M(-12.5%) |
| Sep 2020 | - | -$3.80M(+70.6%) | -$40.34M(+22.7%) |
| Jun 2020 | - | -$12.95M(+1.7%) | -$52.18M(-2.9%) |
| Mar 2020 | - | -$13.17M(-26.6%) | -$50.73M(+10.7%) |
| Dec 2019 | -$56.79M(+36.5%) | -$10.41M(+33.5%) | -$56.79M(+2.0%) |
| Sep 2019 | - | -$15.65M(-36.1%) | -$57.98M(+23.2%) |
| Jun 2019 | - | -$11.50M(+40.2%) | -$75.46M(+23.3%) |
| Mar 2019 | - | -$19.24M(-65.9%) | -$98.39M(-14.2%) |
| Dec 2018 | - | -$11.59M(+65.0%) | -$86.13M(-15.6%) |
| Dec 2018 | -$89.44M(-383.9%) | - | - |
| Sep 2018 | - | -$33.13M(+3.8%) | -$74.53M(-80.0%) |
| Jun 2018 | - | -$34.43M(-393.4%) | -$41.41M(-216.2%) |
| Mar 2018 | - | -$6.98M(-14.1%) | -$13.09M(+29.2%) |
| Jun 2017 | -$18.48M(+14.2%) | -$6.12M(-19.0%) | -$18.48M(+1.4%) |
| Mar 2017 | - | -$5.14M(-7571.6%) | -$18.76M(-0.5%) |
| Dec 2016 | - | -$67.00K(+99.1%) | -$18.66M(+21.5%) |
| Sep 2016 | - | -$7.16M(-12.1%) | -$23.78M(-10.3%) |
| Jun 2016 | -$21.55M(-439.5%) | -$6.39M(-26.7%) | -$21.55M(-6.1%) |
| Mar 2016 | - | -$5.04M(+2.8%) | -$20.31M(-0.2%) |
| Dec 2015 | - | -$5.19M(-5.1%) | -$20.26M(-5.8%) |
| Sep 2015 | - | -$4.93M(+4.1%) | -$19.15M(-401.7%) |
| Jun 2015 | $6.35M(+147.5%) | -$5.15M(-3.0%) | $6.35M(-15.7%) |
| Mar 2015 | - | -$5.00M(-22.7%) | $7.53M(-27.2%) |
| Dec 2014 | - | -$4.08M(-119.8%) | $10.34M(-5.1%) |
| Sep 2014 | - | $20.57M(+618.4%) | $10.90M(+181.6%) |
| Jun 2014 | -$13.36M | -$3.97M(-81.4%) | -$13.36M(-0.1%) |
| Mar 2014 | - | -$2.19M(+37.8%) | -$13.34M(+4.4%) |
| Dec 2013 | - | -$3.51M(+4.7%) | -$13.94M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$3.69M(+6.6%) | -$13.04M(-9.5%) |
| Jun 2013 | -$11.90M(+52.1%) | -$3.95M(-41.3%) | -$11.90M(-16.5%) |
| Mar 2013 | - | -$2.79M(-7.1%) | -$10.21M(-1.1%) |
| Dec 2012 | - | -$2.61M(-2.2%) | -$10.11M(+59.5%) |
| Sep 2012 | - | -$2.55M(-12.8%) | -$24.96M(-0.5%) |
| Jun 2012 | -$24.84M(-187.8%) | -$2.26M(+15.8%) | -$24.84M(-9.3%) |
| Mar 2012 | - | -$2.69M(+84.6%) | -$22.71M(-0.0%) |
| Dec 2011 | - | -$17.46M(-619.4%) | -$22.71M(-185.8%) |
| Sep 2011 | - | -$2.43M(-1633.6%) | -$7.95M(+7.9%) |
| Jun 2011 | -$8.63M(-198.6%) | -$140.00K(+94.8%) | -$8.63M(-288.2%) |
| Mar 2011 | - | -$2.69M(+0.4%) | $4.58M(+0.4%) |
| Dec 2010 | - | -$2.69M(+13.3%) | $4.57M(-36.9%) |
| Sep 2010 | - | -$3.11M(-123.8%) | $7.24M(-17.3%) |
| Jun 2010 | $8.75M(+448.6%) | $13.07M(+583.3%) | $8.75M(+280.3%) |
| Mar 2010 | - | -$2.71M(>-9900.0%) | -$4.85M(-74.3%) |
| Dec 2009 | - | -$24.00K(+98.5%) | -$2.79M(+23.3%) |
| Sep 2009 | - | -$1.59M(-197.9%) | -$3.63M(-44.6%) |
| Jun 2009 | -$2.51M(+96.7%) | -$534.00K(+16.0%) | -$2.51M(+96.2%) |
| Mar 2009 | - | -$636.00K(+26.9%) | -$65.56M(+6.9%) |
| Dec 2008 | - | -$870.00K(-84.7%) | -$70.42M(+6.5%) |
| Sep 2008 | - | -$471.00K(+99.3%) | -$75.35M(+0.4%) |
| Jun 2008 | -$75.67M(+9.4%) | -$63.58M(-1055.8%) | -$75.67M(-196.4%) |
| Mar 2008 | - | -$5.50M(+5.1%) | -$25.53M(+11.2%) |
| Dec 2007 | - | -$5.79M(-628.9%) | -$28.73M(+14.3%) |
| Sep 2007 | - | -$795.00K(+94.1%) | -$33.55M(-797.5%) |
| Jun 2007 | -$83.53M(-84.3%) | -$13.44M(-54.4%) | $4.81M(-66.1%) |
| Mar 2007 | - | -$8.71M(+17.9%) | $14.21M(-17.8%) |
| Dec 2006 | - | -$10.61M(-128.2%) | $17.29M(-21.9%) |
| Sep 2006 | - | $37.56M(+1029.0%) | $22.13M(+203.3%) |
| Jun 2006 | -$45.31M(-255.3%) | -$4.04M(+28.1%) | -$21.43M(+0.8%) |
| Mar 2006 | - | -$5.62M(+2.5%) | -$21.59M(-14.7%) |
| Dec 2005 | - | -$5.76M(+3.8%) | -$18.81M(-18.1%) |
| Sep 2005 | - | -$5.99M(-42.5%) | -$15.92M(-26.3%) |
| Jun 2005 | -$12.75M(-398.3%) | -$4.21M(-47.7%) | -$12.61M(-42.4%) |
| Mar 2005 | - | -$2.85M(+0.9%) | -$8.85M(-32.0%) |
| Dec 2004 | - | -$2.87M(-7.3%) | -$6.71M(-48.2%) |
| Sep 2004 | - | -$2.68M(-495.0%) | -$4.52M(-83.0%) |
| Jun 2004 | -$2.56M(-37.8%) | -$450.10K(+36.0%) | -$2.47M(+5.9%) |
| Mar 2004 | - | -$703.10K(-1.5%) | -$2.63M(-12.2%) |
| Dec 2003 | - | -$692.80K(-10.6%) | -$2.34M(-15.0%) |
| Sep 2003 | - | -$626.20K(-3.7%) | -$2.04M(-14.1%) |
| Jun 2003 | -$1.86M(+17.5%) | -$603.80K(-44.4%) | -$1.78M(-51.1%) |
| Mar 2003 | - | -$418.00K(-7.8%) | -$1.18M(-54.8%) |
| Dec 2002 | - | -$387.80K(-3.3%) | -$763.20K(-103.3%) |
| Sep 2002 | - | -$375.40K | -$375.40K |
| Jun 2002 | -$2.25M(-418.1%) | - | - |
| Jun 2001 | -$434.60K | - | - |
FAQ
- What is EyePoint Pharmaceuticals, Inc. annual net profit?
- What is the all-time high annual net income for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. annual net income year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. quarterly net profit?
- What is the all-time high quarterly net income for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is EyePoint Pharmaceuticals, Inc. TTM net profit?
- What is the all-time high TTM net income for EyePoint Pharmaceuticals, Inc.?
- What is EyePoint Pharmaceuticals, Inc. TTM net income year-on-year change?
What is EyePoint Pharmaceuticals, Inc. annual net profit?
The current annual net income of EYPT is -$130.87M
What is the all-time high annual net income for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high annual net profit is $8.75M
What is EyePoint Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, EYPT annual net profit has changed by -$60.08M (-84.86%)
What is EyePoint Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of EYPT is -$59.43M
What is the all-time high quarterly net income for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high quarterly net profit is $37.56M
What is EyePoint Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, EYPT quarterly net profit has changed by -$28.60M (-92.78%)
What is EyePoint Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of EYPT is -$175.38M
What is the all-time high TTM net income for EyePoint Pharmaceuticals, Inc.?
EyePoint Pharmaceuticals, Inc. all-time high TTM net profit is $22.13M
What is EyePoint Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, EYPT TTM net profit has changed by -$88.56M (-102.00%)